Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700014150

Trial Profile

Clinical Trials Insight: 700014150

Phase of Trial: Phase II

Latest Information Update: 10 Feb 2010

At a glance

  • Drugs Ragweed allergy immunotherapy (Primary)
  • Indications Allergic asthma; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Greer Laboratories
  • Most Recent Events

    • 10 Feb 2010 Results have been published early online in the Journal of Allergy and Clinical Immunology.
    • 15 Mar 2008 Status changed from recruiting to completed.
    • 31 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top